06:53 AM EDT, 04/17/2026 (MT Newswires) -- Bruker's ( BRKR ) Bruker Microbiology & Infection Diagnostics division said Friday it has rolled out molecular diagnostics system MyGenius PRO in Europe.

The new diagnostics system is based on polymerase chain reaction, developed to diagnose infectious diseases, according to the division.

Bruker Microbiology said the MyGenius PRO system automates the complete workflow from patient sample to diagnostic result, adding it developed the system in partnership with ELITechGroup and Hitachi High Tech-Corp.

Additionally, Hitachi will launch the platform in Japan under the LABOSPECT GA-5 trade name, according to the company.